Monographie - Filgrastim - Stabilis 4.0

Poslední aktualizace :
19/11/2024

Įvairūs

Filgrastim

Įpurškimas

Tirpalų stabilumas

Mišinių stabilumas

Stabilumą lemiantys veiksniai

Suderinamumas

Leidimo būdai

Bibliografija

pdf

Prekinis pavadinimas

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Accofil	Belgija, Didžioji Britanija, Vokietija
Biocilin	Meksikas
Duperan	Čilė
Filgen	Argentina
Foltran	Čilė
Granulokine	Graikija, Italija
Hebervital	Kolumbija
Inmunef	Kolumbija
Leucosos	Kolumbija
Lioplim	Čilė
Neupogen	Austrija, Belgija, Danija, Didžioji Britanija, Ispanija, Jungtinės Amerikos Valstijos, Kroatija, Lenkija, Olandija, Pietų Afrikos Respublika, Portugalija, Prancūzija, Slovėnija, Suomija, Švedija, Šveicarija, Turkija
Neutromax	Argentina
Neutropine	Argentina
Nivestim	Belgija, Didžioji Britanija, Norvegija, Olandija, Prancūzija, Vokietija
Ratiograstim	Austrija, Didžioji Britanija, Švedija, Vokietija
Tevagrastim	Didžioji Britanija, Norvegija, Olandija, Švedija, Šveicarija, Vokietija

Bibliografija

Įpurškimas

Bibliografija : Filgrastim

	tipas	leidinys
99	Žurnalas	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104	Žurnalas	Hall PD, Yui D, Lyons S, Bosso JA. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 185-189.
182	Žurnalas	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	Žurnalas	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269	Žurnalas	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128	Laboratorija	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3249	Žurnalas	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256	Žurnalas	Burnett B, Radic I. Stability of Hospira filgrastim following changes to thermal and photic storage conditions. EJHP 2011 ; 17, 5: 49-56.
3474	Laboratorija	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3618	Laboratorija	Filgrastim (Neupogen®) - Summary of Product Characteristics Amgen 2014
3828	plakatas	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakatas	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Žurnalas	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380	Laboratorija	Posaconazole (Noxafil®) - Summary of Product Characteristics Merck Sharp & Dohme Limited 2019
4471	Laboratorija	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019
4521	Žurnalas	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4650	Laboratorija	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales